Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways

• Published in: Journal of translational medicine 2013-10, Vol.11 (1), p.273-273, Article 273
• Main Authors: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ke, Shan, Wang, Shaohong, Ding, Xuemei, Sun, Wenbing, Zheng, Lemin
• Format: Article
• Language: English
• Subjects: Ablation (Surgery); Analysis; Angiogenesis; Animals; Carcinoma, Hepatocellular - enzymology; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - therapy; Care and treatment; Catheter Ablation - methods; Cell adhesion & migration; Cell culture; Cell growth; Cell Line, Tumor; Chromones - pharmacology; Complications and side effects; Development and progression; Disease Progression; Epithelial-Mesenchymal Transition; Flavonoids - pharmacology; Health aspects; Heat; Hepatoma; Humans; Hypoxia; Liver cancer; Liver Neoplasms - enzymology; Liver Neoplasms - pathology; Liver Neoplasms - therapy; MAP Kinase Signaling System; Metastasis; Mice; Mice, Nude; Morpholines - pharmacology; Neoplasm Metastasis; Neurosciences; Patient outcomes; Proto-Oncogene Proteins c-akt - metabolism; Science; Tumors; Vascular endothelial growth factor
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/1479-5876-11-273

Residual tumor progression after insufficient radiofrequency ablation (RFA) has been recently reported. However, whether epithelial-mesenchymal transition (EMT), which is a key process that drives cancer metastasis, is involved in the tumor progression after insufficient RFA is not well understood. Human hepatocellular carcinoma (HCC) cell lines SMMC7721 and Huh7 were used. Insufficient RFA was simulated using a water bath (47°C 5 min, 10 min, 15 min, 20 min and 25 min gradually). MTT assay was used to evaluate the proliferation of HCC cells in vitro. Migration and invasion of HCC cells were determined by transwell assay. The molecular changes in HCC cells after insufficient RFA were evaluated by western blot. LY294002 and PD98059 were used to treat HCC cells. An ectopic nude mice model and a tail vein metastatic assay were used to evaluate the growth and metastatic potential of SMMC7721 cells in vivo after insufficient RFA. SMMC7721 and Huh7 cells after insufficient RFA (named as SMMC7721-H and Huh7-H respectively) exhibited enhanced proliferation, migration and invasion (6.4% and 23.6%, 33.2% and 66.1%, and 44.1% and 57.4% increase respectively) in vitro. Molecular changes of EMT were observed in SMMC7721-H and Huh7-H cells. LY294002 and PD98059 inhibited the EMT of SMMC7721-H and Huh7-H cells. SMMC7721-H cells also exhibited larger tumor size (1440.8±250.3 mm3 versus 1048.56±227.6 mm3) and more lung metastasis (97.4% increase) than SMMC7721 cells in vivo. Higher expression of PCNA, N-cadherin and MMP-2 and MMP-9, was also observed in SMMC7721-H tumors. Insufficient RFA could directly promote the invasiveness and metastasis of HCC cells. Insufficient RFA may promote the EMT of HCC cells through Akt and ERK signaling pathways.